Global Fetal Bovine Serum
Global Fetal Bovine Serum

Fetal Bovine Serum Comprehensive Study by Application (Drug Discovery, Cell Culture Media, Vitro Fertilization, Human and Animal Vaccine production, Diagnostics, Others), End-Users (Research and Academic Institutes, Pharmaceutical Industry, Biotechnology Industry) Players and Region - Global Market Outlook to 2024

Fetal Bovine Serum Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 214 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
The study covers a detailed analysis segmented by key business segments i.e. , by application (Drug Discovery, Cell Culture Media, Vitro Fertilization, Human and Animal Vaccine production, Diagnostics and Others) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Fetal Bovine Serum market throughout the predicted period.

The competition is expected to become even more intense in the coming years with the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Fetal Bovine Serum market analysis report suggests strategies Players can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, including:
  • Merck KGaA (Germany)
  • Atlanta Biologicals Inc. (Unites States)
  • Tissue Culture Biologicals (Unites States)
  • HiMedia Laboratories (India)
  • Bovogen Biologicals Pty Ltd. (Australia)
  • Rocky Mountain Biologicals (Unites States)
  • GE Healthcare (Unites States)
  • PAN-Biotech (Germany)
  • Sigma-Aldrich Co. LLC. (Unites States)
  • ExCell Bio (China)


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies.

Market Trend
Upsurge in R&D Activities toward the Introduction of Novel Biopharmaceuticals
Restraints
  • Availability of Alternatives

Opportunities
Increasing Number of Academic Research Institutes and Increase in Investments and Funding For Research Interventions

Key highlights of the Global Fetal Bovine Serum market Study:
• CAGR of the market during the forecast period 2018-2024
• Detailed information on factors that will accelerate the growth of the Fetal Bovine Serum market for the next five years.
• Forecast of the Global Fetal Bovine Serum market size and its contribution to the parent market by type, application and by country.
• Insights on upcoming trends and changes in consumer behaviour
• Uncovering market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Fetal Bovine Serum Players

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Fetal Bovine Serum market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Fetal Bovine Serum market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Manufacturers of Fetal Bovine Serum, Suppliers of Fetal Bovine Serum, Wholesalers, Distributors and Retailers of Fetal Bovine Serum, Pharmaceutical Industry, Research Organization and Governmental Bodies.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Application
  • Drug Discovery
  • Cell Culture Media
  • Vitro Fertilization
  • Human and Animal Vaccine production
  • Diagnostics
  • Others
By End-Users
  • Research and Academic Institutes
  • Pharmaceutical Industry
  • Biotechnology Industry

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing from Pharmaceutical and Biotechnology Industry
      • 3.2.2. Increase in Demand from Traditional Users of Serum
    • 3.3. Market Challenges
      • 3.3.1. Rising Prices of FBS
    • 3.4. Market Trends
      • 3.4.1. Upsurge in R&D Activities toward the Introduction of Novel Biopharmaceuticals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fetal Bovine Serum, by Application, End-Users and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Fetal Bovine Serum (Value)
      • 5.2.1. Global Fetal Bovine Serum by: Application (Value)
        • 5.2.1.1. Drug Discovery
        • 5.2.1.2. Cell Culture Media
        • 5.2.1.3. Vitro Fertilization
        • 5.2.1.4. Human and Animal Vaccine production
        • 5.2.1.5. Diagnostics
        • 5.2.1.6. Others
      • 5.2.2. Global Fetal Bovine Serum by: End-Users (Value)
        • 5.2.2.1. Research and Academic Institutes
        • 5.2.2.2. Pharmaceutical Industry
        • 5.2.2.3. Biotechnology Industry
      • 5.2.3. Global Fetal Bovine Serum Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Fetal Bovine Serum (Volume)
      • 5.3.1. Global Fetal Bovine Serum by: Application (Volume)
        • 5.3.1.1. Drug Discovery
        • 5.3.1.2. Cell Culture Media
        • 5.3.1.3. Vitro Fertilization
        • 5.3.1.4. Human and Animal Vaccine production
        • 5.3.1.5. Diagnostics
        • 5.3.1.6. Others
      • 5.3.2. Global Fetal Bovine Serum by: End-Users (Volume)
        • 5.3.2.1. Research and Academic Institutes
        • 5.3.2.2. Pharmaceutical Industry
        • 5.3.2.3. Biotechnology Industry
      • 5.3.3. Global Fetal Bovine Serum Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Fetal Bovine Serum (Price)
  • 6. Fetal Bovine Serum: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck KGaA (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Atlanta Biologicals Inc. (Unites States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Tissue Culture Biologicals (Unites States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. HiMedia Laboratories (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bovogen Biologicals Pty Ltd. (Australia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Rocky Mountain Biologicals (Unites States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GE Healthcare (Unites States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PAN-Biotech (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sigma-Aldrich Co. LLC. (Unites States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ExCell Bio (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Fetal Bovine Serum Sale, by Application, End-Users and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Fetal Bovine Serum (Value)
      • 7.2.1. Global Fetal Bovine Serum by: Application (Value)
        • 7.2.1.1. Drug Discovery
        • 7.2.1.2. Cell Culture Media
        • 7.2.1.3. Vitro Fertilization
        • 7.2.1.4. Human and Animal Vaccine production
        • 7.2.1.5. Diagnostics
        • 7.2.1.6. Others
      • 7.2.2. Global Fetal Bovine Serum by: End-Users (Value)
        • 7.2.2.1. Research and Academic Institutes
        • 7.2.2.2. Pharmaceutical Industry
        • 7.2.2.3. Biotechnology Industry
      • 7.2.3. Global Fetal Bovine Serum Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Fetal Bovine Serum (Volume)
      • 7.3.1. Global Fetal Bovine Serum by: Application (Volume)
        • 7.3.1.1. Drug Discovery
        • 7.3.1.2. Cell Culture Media
        • 7.3.1.3. Vitro Fertilization
        • 7.3.1.4. Human and Animal Vaccine production
        • 7.3.1.5. Diagnostics
        • 7.3.1.6. Others
      • 7.3.2. Global Fetal Bovine Serum by: End-Users (Volume)
        • 7.3.2.1. Research and Academic Institutes
        • 7.3.2.2. Pharmaceutical Industry
        • 7.3.2.3. Biotechnology Industry
      • 7.3.3. Global Fetal Bovine Serum Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Fetal Bovine Serum (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fetal Bovine Serum: by Application(USD Million)
  • Table 2. Fetal Bovine Serum Drug Discovery , by Region USD Million (2013-2018)
  • Table 3. Fetal Bovine Serum Cell Culture Media , by Region USD Million (2013-2018)
  • Table 4. Fetal Bovine Serum Vitro Fertilization , by Region USD Million (2013-2018)
  • Table 5. Fetal Bovine Serum Human and Animal Vaccine production , by Region USD Million (2013-2018)
  • Table 6. Fetal Bovine Serum Diagnostics , by Region USD Million (2013-2018)
  • Table 7. Fetal Bovine Serum Others , by Region USD Million (2013-2018)
  • Table 8. Fetal Bovine Serum: by End-Users(USD Million)
  • Table 9. Fetal Bovine Serum Research and Academic Institutes , by Region USD Million (2013-2018)
  • Table 10. Fetal Bovine Serum Pharmaceutical Industry , by Region USD Million (2013-2018)
  • Table 11. Fetal Bovine Serum Biotechnology Industry , by Region USD Million (2013-2018)
  • Table 12. South America Fetal Bovine Serum, by Country USD Million (2013-2018)
  • Table 13. South America Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 14. South America Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 15. Brazil Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 16. Brazil Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 17. Argentina Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 18. Argentina Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 19. Rest of South America Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 20. Rest of South America Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 21. Asia Pacific Fetal Bovine Serum, by Country USD Million (2013-2018)
  • Table 22. Asia Pacific Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 23. Asia Pacific Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 24. China Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 25. China Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 26. Japan Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 27. Japan Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 28. India Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 29. India Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 30. South Korea Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 31. South Korea Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 32. Taiwan Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 33. Taiwan Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 34. Australia Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 35. Australia Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 36. Rest of Asia-Pacific Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 37. Rest of Asia-Pacific Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 38. Europe Fetal Bovine Serum, by Country USD Million (2013-2018)
  • Table 39. Europe Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 40. Europe Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 41. Germany Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 42. Germany Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 43. France Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 44. France Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 45. Italy Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 46. Italy Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 47. United Kingdom Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 48. United Kingdom Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 49. Netherlands Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 50. Netherlands Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 51. Rest of Europe Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 52. Rest of Europe Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 53. MEA Fetal Bovine Serum, by Country USD Million (2013-2018)
  • Table 54. MEA Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 55. MEA Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 56. Middle East Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 57. Middle East Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 58. Africa Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 59. Africa Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 60. North America Fetal Bovine Serum, by Country USD Million (2013-2018)
  • Table 61. North America Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 62. North America Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 63. United States Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 64. United States Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 65. Canada Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 66. Canada Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 67. Mexico Fetal Bovine Serum, by Application USD Million (2013-2018)
  • Table 68. Mexico Fetal Bovine Serum, by End-Users USD Million (2013-2018)
  • Table 69. Fetal Bovine Serum Sales: by Application(ml)
  • Table 70. Fetal Bovine Serum Sales Drug Discovery , by Region ml (2013-2018)
  • Table 71. Fetal Bovine Serum Sales Cell Culture Media , by Region ml (2013-2018)
  • Table 72. Fetal Bovine Serum Sales Vitro Fertilization , by Region ml (2013-2018)
  • Table 73. Fetal Bovine Serum Sales Human and Animal Vaccine production , by Region ml (2013-2018)
  • Table 74. Fetal Bovine Serum Sales Diagnostics , by Region ml (2013-2018)
  • Table 75. Fetal Bovine Serum Sales Others , by Region ml (2013-2018)
  • Table 76. Fetal Bovine Serum Sales: by End-Users(ml)
  • Table 77. Fetal Bovine Serum Sales Research and Academic Institutes , by Region ml (2013-2018)
  • Table 78. Fetal Bovine Serum Sales Pharmaceutical Industry , by Region ml (2013-2018)
  • Table 79. Fetal Bovine Serum Sales Biotechnology Industry , by Region ml (2013-2018)
  • Table 80. South America Fetal Bovine Serum Sales, by Country ml (2013-2018)
  • Table 81. South America Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 82. South America Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 83. Brazil Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 84. Brazil Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 85. Argentina Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 86. Argentina Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 87. Rest of South America Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 88. Rest of South America Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 89. Asia Pacific Fetal Bovine Serum Sales, by Country ml (2013-2018)
  • Table 90. Asia Pacific Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 91. Asia Pacific Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 92. China Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 93. China Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 94. Japan Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 95. Japan Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 96. India Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 97. India Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 98. South Korea Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 99. South Korea Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 100. Taiwan Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 101. Taiwan Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 102. Australia Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 103. Australia Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 104. Rest of Asia-Pacific Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 105. Rest of Asia-Pacific Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 106. Europe Fetal Bovine Serum Sales, by Country ml (2013-2018)
  • Table 107. Europe Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 108. Europe Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 109. Germany Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 110. Germany Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 111. France Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 112. France Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 113. Italy Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 114. Italy Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 115. United Kingdom Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 116. United Kingdom Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 117. Netherlands Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 118. Netherlands Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 119. Rest of Europe Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 120. Rest of Europe Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 121. MEA Fetal Bovine Serum Sales, by Country ml (2013-2018)
  • Table 122. MEA Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 123. MEA Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 124. Middle East Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 125. Middle East Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 126. Africa Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 127. Africa Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 128. North America Fetal Bovine Serum Sales, by Country ml (2013-2018)
  • Table 129. North America Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 130. North America Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 131. United States Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 132. United States Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 133. Canada Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 134. Canada Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 135. Mexico Fetal Bovine Serum Sales, by Application ml (2013-2018)
  • Table 136. Mexico Fetal Bovine Serum Sales, by End-Users ml (2013-2018)
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Fetal Bovine Serum: by Application(USD Million)
  • Table 148. Fetal Bovine Serum Drug Discovery , by Region USD Million (2019-2024)
  • Table 149. Fetal Bovine Serum Cell Culture Media , by Region USD Million (2019-2024)
  • Table 150. Fetal Bovine Serum Vitro Fertilization , by Region USD Million (2019-2024)
  • Table 151. Fetal Bovine Serum Human and Animal Vaccine production , by Region USD Million (2019-2024)
  • Table 152. Fetal Bovine Serum Diagnostics , by Region USD Million (2019-2024)
  • Table 153. Fetal Bovine Serum Others , by Region USD Million (2019-2024)
  • Table 154. Fetal Bovine Serum: by End-Users(USD Million)
  • Table 155. Fetal Bovine Serum Research and Academic Institutes , by Region USD Million (2019-2024)
  • Table 156. Fetal Bovine Serum Pharmaceutical Industry , by Region USD Million (2019-2024)
  • Table 157. Fetal Bovine Serum Biotechnology Industry , by Region USD Million (2019-2024)
  • Table 158. South America Fetal Bovine Serum, by Country USD Million (2019-2024)
  • Table 159. South America Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 160. South America Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 161. Brazil Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 162. Brazil Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 163. Argentina Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 164. Argentina Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 165. Rest of South America Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 166. Rest of South America Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 167. Asia Pacific Fetal Bovine Serum, by Country USD Million (2019-2024)
  • Table 168. Asia Pacific Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 169. Asia Pacific Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 170. China Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 171. China Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 172. Japan Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 173. Japan Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 174. India Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 175. India Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 176. South Korea Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 177. South Korea Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 178. Taiwan Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 179. Taiwan Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 180. Australia Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 181. Australia Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 182. Rest of Asia-Pacific Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 183. Rest of Asia-Pacific Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 184. Europe Fetal Bovine Serum, by Country USD Million (2019-2024)
  • Table 185. Europe Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 186. Europe Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 187. Germany Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 188. Germany Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 189. France Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 190. France Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 191. Italy Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 192. Italy Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 193. United Kingdom Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 194. United Kingdom Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 195. Netherlands Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 196. Netherlands Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 197. Rest of Europe Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 198. Rest of Europe Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 199. MEA Fetal Bovine Serum, by Country USD Million (2019-2024)
  • Table 200. MEA Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 201. MEA Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 202. Middle East Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 203. Middle East Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 204. Africa Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 205. Africa Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 206. North America Fetal Bovine Serum, by Country USD Million (2019-2024)
  • Table 207. North America Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 208. North America Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 209. United States Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 210. United States Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 211. Canada Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 212. Canada Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 213. Mexico Fetal Bovine Serum, by Application USD Million (2019-2024)
  • Table 214. Mexico Fetal Bovine Serum, by End-Users USD Million (2019-2024)
  • Table 215. Fetal Bovine Serum Sales: by Application(ml)
  • Table 216. Fetal Bovine Serum Sales Drug Discovery , by Region ml (2019-2024)
  • Table 217. Fetal Bovine Serum Sales Cell Culture Media , by Region ml (2019-2024)
  • Table 218. Fetal Bovine Serum Sales Vitro Fertilization , by Region ml (2019-2024)
  • Table 219. Fetal Bovine Serum Sales Human and Animal Vaccine production , by Region ml (2019-2024)
  • Table 220. Fetal Bovine Serum Sales Diagnostics , by Region ml (2019-2024)
  • Table 221. Fetal Bovine Serum Sales Others , by Region ml (2019-2024)
  • Table 222. Fetal Bovine Serum Sales: by End-Users(ml)
  • Table 223. Fetal Bovine Serum Sales Research and Academic Institutes , by Region ml (2019-2024)
  • Table 224. Fetal Bovine Serum Sales Pharmaceutical Industry , by Region ml (2019-2024)
  • Table 225. Fetal Bovine Serum Sales Biotechnology Industry , by Region ml (2019-2024)
  • Table 226. South America Fetal Bovine Serum Sales, by Country ml (2019-2024)
  • Table 227. South America Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 228. South America Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 229. Brazil Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 230. Brazil Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 231. Argentina Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 232. Argentina Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 233. Rest of South America Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 234. Rest of South America Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 235. Asia Pacific Fetal Bovine Serum Sales, by Country ml (2019-2024)
  • Table 236. Asia Pacific Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 237. Asia Pacific Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 238. China Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 239. China Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 240. Japan Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 241. Japan Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 242. India Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 243. India Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 244. South Korea Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 245. South Korea Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 246. Taiwan Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 247. Taiwan Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 248. Australia Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 249. Australia Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 250. Rest of Asia-Pacific Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 251. Rest of Asia-Pacific Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 252. Europe Fetal Bovine Serum Sales, by Country ml (2019-2024)
  • Table 253. Europe Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 254. Europe Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 255. Germany Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 256. Germany Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 257. France Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 258. France Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 259. Italy Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 260. Italy Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 261. United Kingdom Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 262. United Kingdom Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 263. Netherlands Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 264. Netherlands Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 265. Rest of Europe Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 266. Rest of Europe Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 267. MEA Fetal Bovine Serum Sales, by Country ml (2019-2024)
  • Table 268. MEA Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 269. MEA Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 270. Middle East Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 271. Middle East Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 272. Africa Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 273. Africa Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 274. North America Fetal Bovine Serum Sales, by Country ml (2019-2024)
  • Table 275. North America Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 276. North America Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 277. United States Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 278. United States Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 279. Canada Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 280. Canada Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 281. Mexico Fetal Bovine Serum Sales, by Application ml (2019-2024)
  • Table 282. Mexico Fetal Bovine Serum Sales, by End-Users ml (2019-2024)
  • Table 283. Research Programs/Design for This Report
  • Table 284. Key Data Information from Secondary Sources
  • Table 285. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fetal Bovine Serum: by Application USD Million (2013-2018)
  • Figure 5. Global Fetal Bovine Serum: by End-Users USD Million (2013-2018)
  • Figure 6. South America Fetal Bovine Serum Share (%), by Country
  • Figure 7. Asia Pacific Fetal Bovine Serum Share (%), by Country
  • Figure 8. Europe Fetal Bovine Serum Share (%), by Country
  • Figure 9. MEA Fetal Bovine Serum Share (%), by Country
  • Figure 10. North America Fetal Bovine Serum Share (%), by Country
  • Figure 11. Global Fetal Bovine Serum: by Application ml (2013-2018)
  • Figure 12. Global Fetal Bovine Serum: by End-Users ml (2013-2018)
  • Figure 13. South America Fetal Bovine Serum Share (%), by Country
  • Figure 14. Asia Pacific Fetal Bovine Serum Share (%), by Country
  • Figure 15. Europe Fetal Bovine Serum Share (%), by Country
  • Figure 16. MEA Fetal Bovine Serum Share (%), by Country
  • Figure 17. North America Fetal Bovine Serum Share (%), by Country
  • Figure 18. Global Fetal Bovine Serum share by Players 2018 (%)
  • Figure 19. Global Fetal Bovine Serum share by Players (Top 3) 2018(%)
  • Figure 20. Global Fetal Bovine Serum share by Players (Top 5) 2018(%)
  • Figure 21. BCG Matrix for key Companies
  • Figure 22. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Merck KGaA (Germany) Revenue: by Geography 2018
  • Figure 24. Atlanta Biologicals Inc. (Unites States) Revenue, Net Income and Gross profit
  • Figure 25. Atlanta Biologicals Inc. (Unites States) Revenue: by Geography 2018
  • Figure 26. Tissue Culture Biologicals (Unites States) Revenue, Net Income and Gross profit
  • Figure 27. Tissue Culture Biologicals (Unites States) Revenue: by Geography 2018
  • Figure 28. HiMedia Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 29. HiMedia Laboratories (India) Revenue: by Geography 2018
  • Figure 30. Bovogen Biologicals Pty Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 31. Bovogen Biologicals Pty Ltd. (Australia) Revenue: by Geography 2018
  • Figure 32. Rocky Mountain Biologicals (Unites States) Revenue, Net Income and Gross profit
  • Figure 33. Rocky Mountain Biologicals (Unites States) Revenue: by Geography 2018
  • Figure 34. GE Healthcare (Unites States) Revenue, Net Income and Gross profit
  • Figure 35. GE Healthcare (Unites States) Revenue: by Geography 2018
  • Figure 36. PAN-Biotech (Germany) Revenue, Net Income and Gross profit
  • Figure 37. PAN-Biotech (Germany) Revenue: by Geography 2018
  • Figure 38. Sigma-Aldrich Co. LLC. (Unites States) Revenue, Net Income and Gross profit
  • Figure 39. Sigma-Aldrich Co. LLC. (Unites States) Revenue: by Geography 2018
  • Figure 40. ExCell Bio (China) Revenue, Net Income and Gross profit
  • Figure 41. ExCell Bio (China) Revenue: by Geography 2018
  • Figure 42. Global Fetal Bovine Serum: by Application USD Million (2019-2024)
  • Figure 43. Global Fetal Bovine Serum: by End-Users USD Million (2019-2024)
  • Figure 44. South America Fetal Bovine Serum Share (%), by Country
  • Figure 45. Asia Pacific Fetal Bovine Serum Share (%), by Country
  • Figure 46. Europe Fetal Bovine Serum Share (%), by Country
  • Figure 47. MEA Fetal Bovine Serum Share (%), by Country
  • Figure 48. North America Fetal Bovine Serum Share (%), by Country
  • Figure 49. Global Fetal Bovine Serum: by Application ml (2019-2024)
  • Figure 50. Global Fetal Bovine Serum: by End-Users ml (2019-2024)
  • Figure 51. South America Fetal Bovine Serum Share (%), by Country
  • Figure 52. Asia Pacific Fetal Bovine Serum Share (%), by Country
  • Figure 53. Europe Fetal Bovine Serum Share (%), by Country
  • Figure 54. MEA Fetal Bovine Serum Share (%), by Country
  • Figure 55. North America Fetal Bovine Serum Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Merck KGaA (Germany)
  • Atlanta Biologicals Inc. (Unites States)
  • Tissue Culture Biologicals (Unites States)
  • HiMedia Laboratories (India)
  • Bovogen Biologicals Pty Ltd. (Australia)
  • Rocky Mountain Biologicals (Unites States)
  • GE Healthcare (Unites States)
  • PAN-Biotech (Germany)
  • Sigma-Aldrich Co. LLC. (Unites States)
  • ExCell Bio (China)
Additional players considered in the study are as follows:
Bio Nutrientes Brasil (Brazil) , Seroxlab (Germany) , Peak Serum (United States) , Biological Industries (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation